Fingerprint
Dive into the research topics of 'Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically